Diethylphosphonoaceticum acidum CAS 3095-95-2 Puritas >99.5% (HPLC)
Ruifu Chemical Supple intermedia de Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
acetaldehyda Diethyl acetalis CAS 3616-56-6
trans-4-dimethylaminocrotonic Acidum hydrochloridum CAS 848133-35-75
Diethylphosphonoaceticum acidum CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-one CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl) -7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineCAS 314771-88-5
Nomen chemicum | Diethylphosphonoaceticum acidum |
Synonyma | 2-(Diethoxyphosphoryl) Acidum aceticum;(Diethoxyphosphinyl) Acidum aceticum;Diethyl Carboxymethylphosphonate;NSC 272281 |
CAS Number | 3095-95-2 |
CATTUS Number | RF-PI2024 |
Stock Status | In Stock, Productio Capacitas 30MT/Mense |
Formulae hypotheticae | (C2H5O)2P(O)CH2CO2H |
M. Pondus | 196.14 |
Ferveret | 150℃/0.05 mmHg (lit.) |
Density | 1.220 g/mL ad 25℃ (lit.) |
Index refractivus | n20/D 1.445 (lit.) |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Hyalina Liquid |
Lepidium sativum (HPLC) | Retentionis tempus summi culminis ex specimen consecutum est intra 5% of specimen referentis. |
Puritas / Analysis Methodus | >99.5% (HPLC) |
Infrared Imaginis | Conformat ut Structure |
Proton NMR Spectrum | Conformat ut Structure |
Humor (KF) | <0.50% |
Totalis immunditias | <0.50% |
Test Standard | Enterprise Standard |
Consuetudinem | Afatinib Dimaleate (CAS: 850140-73-7) |
sarcina: Fluorinated Utrem, 25kg/Drum, vel secundum exigentiam mos
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Diethylphosphonoaceticum acidum (CAS: 3095-95-2), Actus sicut nucleophilus ad additiones nucleophilicae reactiones pro synthesi allenae epoxidum Reactant pro: studiis Stereoselectivity Staudinger reaction;Formatio enantioselectiva diolorum per epoxidationem et hydropicos reactiones;Horner-Wadsworth-Emmonum profectae;Chelation remota regente Hiberniae-Claisen rearrangement;Ugi-Dieckmann reactiones ad synthesin derivationum acidi tetramici;Solebant phosphonoester intermedia facere ad motus intramoleculares HEW.Diethylphosphonoaceticum acidum medium ex Afatinib Dimaleate (CAS: 850140-73-7).Afatinib Dimaleate probatus est ab US Cibus et Drug Administration (FDA) in 2013 pro curatione cancri cellae non parvae (NSCLC).Speciatim probatum est aegris exhibere tumores metastaticos NSCLC, qui continent incrementum epidermalium receptorem (EGFR) exon deletionum vel exon 21 mutationum.Afatinib Dimaleate est covalens inhibitor of ErbB tyrosini kinases (tyk), quae gubernat ErbB significat immedicabile ligamen EGFR tyk sites ligandi.